AR032240A1 - Una composicion de vacuna profilactica y terapeutica que comprenden proteinas de envoltura purificadas de virus de hepatitis c - Google Patents
Una composicion de vacuna profilactica y terapeutica que comprenden proteinas de envoltura purificadas de virus de hepatitis cInfo
- Publication number
- AR032240A1 AR032240A1 ARP020100104A ARP020100104A AR032240A1 AR 032240 A1 AR032240 A1 AR 032240A1 AR P020100104 A ARP020100104 A AR P020100104A AR P020100104 A ARP020100104 A AR P020100104A AR 032240 A1 AR032240 A1 AR 032240A1
- Authority
- AR
- Argentina
- Prior art keywords
- protein
- proteins
- therapeutic vaccine
- compilition
- profilactic
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 229940021747 therapeutic vaccine Drugs 0.000 title abstract 2
- 241000711557 Hepacivirus Species 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 101710125507 Integrase/recombinase Proteins 0.000 abstract 2
- 101710185720 Putative ethidium bromide resistance protein Proteins 0.000 abstract 2
- 238000010494 dissociation reaction Methods 0.000 abstract 2
- 230000005593 dissociations Effects 0.000 abstract 2
- 101710091045 Envelope protein Proteins 0.000 abstract 1
- 101710188315 Protein X Proteins 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000002934 lysing effect Effects 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 229940021993 prophylactic vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26066901P | 2001-01-11 | 2001-01-11 | |
| US31576801P | 2001-08-30 | 2001-08-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR032240A1 true AR032240A1 (es) | 2003-10-29 |
Family
ID=26948130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020100104A AR032240A1 (es) | 2001-01-11 | 2002-01-14 | Una composicion de vacuna profilactica y terapeutica que comprenden proteinas de envoltura purificadas de virus de hepatitis c |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1463753A2 (cs) |
| KR (1) | KR20020089371A (cs) |
| CN (1) | CN1547588A (cs) |
| AR (1) | AR032240A1 (cs) |
| AU (1) | AU2002238502B2 (cs) |
| BR (1) | BR0203518A (cs) |
| CA (1) | CA2400643A1 (cs) |
| CZ (1) | CZ20032164A3 (cs) |
| HU (1) | HUP0302416A2 (cs) |
| IL (1) | IL151033A0 (cs) |
| MX (1) | MXPA02008886A (cs) |
| NO (1) | NO20024325L (cs) |
| PL (1) | PL363175A1 (cs) |
| RU (1) | RU2313363C2 (cs) |
| TR (1) | TR200202169T1 (cs) |
| WO (1) | WO2002055548A2 (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR035867A1 (es) | 2001-04-24 | 2004-07-21 | Innogenetics Nv | Una particula semejante a un virus hcv formada por una proteina de envoltura de hcv, un metodo para formar dicha particula, un medicamento que la contiene, una vacuna, un metodo de deteccion, un kit de diagnostico, el uso de cepas de hansenula o saccharomyces para la expresion de una proteina hcv, e |
| EP1558283A2 (en) * | 2002-11-08 | 2005-08-03 | Innogenetics N.V. | Hcv vaccine compositions comprising e1 and ns3 peptides |
| EP1561470A1 (en) * | 2003-06-20 | 2005-08-10 | Innogenetics N.V. | HCV vaccines comprising the envelope-1 (E1) protein or the corresponding DNA and at least one antiviral agent |
| EP2267004A3 (en) * | 2003-09-22 | 2011-04-27 | Green Peptide Co., Ltd. | Peptide derived from hepatitis C virus |
| CN100365124C (zh) * | 2005-10-27 | 2008-01-30 | 云南大学 | 一段丙型肝炎病毒特异性cDNA序列的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0721505T4 (da) * | 1994-07-29 | 2006-08-14 | Innogenetics Nv | Rensede hepatitis C-virus-kappeproteiner til diagnostisk og terapeutisk anvendelse |
-
2002
- 2002-01-11 TR TR2002/02169T patent/TR200202169T1/xx unknown
- 2002-01-11 KR KR1020027011431A patent/KR20020089371A/ko active IP Right Grant
- 2002-01-11 HU HU0302416A patent/HUP0302416A2/hu unknown
- 2002-01-11 CZ CZ20032164A patent/CZ20032164A3/cs unknown
- 2002-01-11 RU RU2002121632/15A patent/RU2313363C2/ru not_active IP Right Cessation
- 2002-01-11 PL PL02363175A patent/PL363175A1/xx unknown
- 2002-01-11 MX MXPA02008886A patent/MXPA02008886A/es active IP Right Grant
- 2002-01-11 IL IL15103302A patent/IL151033A0/xx unknown
- 2002-01-11 CN CNA028006097A patent/CN1547588A/zh active Pending
- 2002-01-11 WO PCT/EP2002/000219 patent/WO2002055548A2/en active IP Right Grant
- 2002-01-11 CA CA002400643A patent/CA2400643A1/en not_active Abandoned
- 2002-01-11 AU AU2002238502A patent/AU2002238502B2/en not_active Ceased
- 2002-01-11 BR BR0203518-9A patent/BR0203518A/pt not_active Withdrawn
- 2002-01-11 EP EP02704649A patent/EP1463753A2/en not_active Withdrawn
- 2002-01-14 AR ARP020100104A patent/AR032240A1/es unknown
- 2002-09-10 NO NO20024325A patent/NO20024325L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL363175A1 (en) | 2004-11-15 |
| WO2002055548A3 (en) | 2004-08-05 |
| CA2400643A1 (en) | 2002-07-18 |
| TR200202169T1 (tr) | 2004-06-21 |
| CZ20032164A3 (cs) | 2003-10-15 |
| RU2313363C2 (ru) | 2007-12-27 |
| AU2002238502B2 (en) | 2007-09-06 |
| CN1547588A (zh) | 2004-11-17 |
| BR0203518A (pt) | 2002-12-17 |
| WO2002055548A8 (en) | 2002-10-31 |
| EP1463753A2 (en) | 2004-10-06 |
| WO2002055548A2 (en) | 2002-07-18 |
| NO20024325L (no) | 2002-11-11 |
| AU2002238502B9 (en) | 2002-07-24 |
| HUP0302416A2 (hu) | 2003-10-28 |
| NO20024325D0 (no) | 2002-09-10 |
| AU2002238502A1 (en) | 2002-07-24 |
| KR20020089371A (ko) | 2002-11-29 |
| MXPA02008886A (es) | 2003-04-25 |
| RU2002121632A (ru) | 2004-03-20 |
| IL151033A0 (en) | 2003-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2174957T3 (es) | Proteinas purificadas de envoltura de virus de la hepatitis c para uso diagnostico y terapeutico. | |
| NO20052136L (no) | Vaksine mot Hepatitt C-virus (HCV). | |
| PT1090033E (pt) | Particulas de proteinas de envelope do hcv: utilizacao para vacinacao | |
| EA200701869A1 (ru) | Пептидомиметические ингибиторы протеазы | |
| MXPA02011545A (es) | Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela. | |
| ATE327246T1 (de) | Hepatitis c tripeptid inhibitoren | |
| WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
| NO20044897L (no) | Hepatitt C virus inhibitorer | |
| WO2006041866A3 (en) | Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes | |
| JP2003528887A5 (cs) | ||
| ATE320493T1 (de) | Modifizierung des hepatitis b kernantigens | |
| BR0312474A (pt) | Partìcula viral adjuvante | |
| WO2002086100A3 (en) | Expression of core-glycosylated hcv envelope proteins in yeast | |
| CL2020000295A1 (es) | Métodos de terapia génica del factor viii (fviii) | |
| HK1047892A1 (en) | Hcv vaccine compositions | |
| MXPA04005891A (es) | Proteinas envolventes del virus de hepatitis c purificadas para diagnostico y uso terapeutico. | |
| AR032240A1 (es) | Una composicion de vacuna profilactica y terapeutica que comprenden proteinas de envoltura purificadas de virus de hepatitis c | |
| BR0206995A (pt) | Tratamento do vìrus da hepatite b | |
| WO2004041853A3 (en) | Hcv vaccine compositions comprising e1 and ns3 peptides | |
| AR041515A1 (es) | Vacuna a dna contra el virus de papiloma humano | |
| DE60229126D1 (de) | Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs | |
| RU2004104357A (ru) | Вакцинный состав, потенцированный комбинацией днк и антигена | |
| ECSP003414A (es) | Peptidos macrociclicos activos frente al virus de la hepatitis c | |
| JP2004525885A5 (cs) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |